BICO Group AB

11
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0013647385
SEK
16.82
-0.72 (-4.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
BICO Group AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,577.00
-81.00
-797.00
-34.00
-213.00
-54.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
112.00
48.00
183.00
-266.00
-348.00
-90.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
68.00
158.00
178.00
-269.00
-409.00
-79.00
Cash Flow from Investing Activities
709.00
128.00
-129.00
212.00
-4,453.00
-827.00
Cash Flow from Financing Activities
-455.00
-200.00
-102.00
455.00
4,900.00
1,308.00
Net Cash Inflow / Outflow
335.00
85.00
-64.00
444.00
46.00
395.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
13.00
0.00
-10.00
45.00
9.00
-6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of BICO Group AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-1577.4
17.382
-1,594.00
-9174.91%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
112.8
-5.161
117.00
2285.62%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
68.4
91.53
-23.00
-25.27%
Cash Flow from Investing Activities
709.3
-54.171
763.00
1409.37%
Cash Flow from Financing Activities
-455.1
-29.936
-426.00
-1420.24%
Net Cash Inflow / Outflow
335.9
5.944
330.00
5551.08%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
13.3
-1.479
14.00
999.26%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -56.82% vs -11.21% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
68.40
158.40
-56.82%